DZ2700A1 - Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques. - Google Patents

Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques.

Info

Publication number
DZ2700A1
DZ2700A1 DZ990001A DZ990001A DZ2700A1 DZ 2700 A1 DZ2700 A1 DZ 2700A1 DZ 990001 A DZ990001 A DZ 990001A DZ 990001 A DZ990001 A DZ 990001A DZ 2700 A1 DZ2700 A1 DZ 2700A1
Authority
DZ
Algeria
Prior art keywords
inflammatory
serving
analgesic agents
substituted indoles
indoles
Prior art date
Application number
DZ990001A
Other languages
English (en)
Inventor
Kazunari Nakao
Rodney William Stevens
Kiyoshi Kawamura
Chikara Koike
Stephane Caron
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2700A1 publication Critical patent/DZ2700A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ990001A 1998-01-05 1999-01-04 Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques. DZ2700A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9800003 1998-01-05

Publications (1)

Publication Number Publication Date
DZ2700A1 true DZ2700A1 (fr) 2003-09-01

Family

ID=11004645

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990001A DZ2700A1 (fr) 1998-01-05 1999-01-04 Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques.

Country Status (39)

Country Link
US (1) US6608070B1 (fr)
EP (1) EP1045833B1 (fr)
JP (1) JP3347136B2 (fr)
KR (1) KR100404054B1 (fr)
CN (1) CN1284064A (fr)
AP (1) AP869A (fr)
AR (1) AR016977A1 (fr)
AT (1) ATE308519T1 (fr)
AU (1) AU748107B2 (fr)
BG (1) BG104643A (fr)
BR (1) BR9813124A (fr)
CA (1) CA2316863A1 (fr)
CO (1) CO4970807A1 (fr)
DE (1) DE69832200T2 (fr)
DZ (1) DZ2700A1 (fr)
EA (1) EA200000614A1 (fr)
ES (1) ES2255190T3 (fr)
GT (1) GT199800205A (fr)
HN (1) HN1997000098A (fr)
HR (1) HRP20000454A2 (fr)
HU (1) HUP0102922A3 (fr)
ID (1) ID24876A (fr)
IL (1) IL136885A0 (fr)
IS (1) IS5532A (fr)
MA (1) MA24736A1 (fr)
NO (1) NO20003451L (fr)
OA (1) OA11441A (fr)
PA (1) PA8466201A1 (fr)
PE (1) PE20000055A1 (fr)
PL (1) PL341696A1 (fr)
SA (1) SA99191299A (fr)
SK (1) SK9912000A3 (fr)
TN (1) TNSN99001A1 (fr)
TR (1) TR200001906T2 (fr)
TW (1) TW436482B (fr)
UY (2) UY25332A1 (fr)
WO (1) WO1999035130A1 (fr)
YU (1) YU41600A (fr)
ZA (1) ZA9911B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555540B1 (en) * 1999-06-30 2003-04-29 Pfizer Inc Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors
MXPA00006605A (es) 1999-07-02 2004-12-09 Pfizer Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos.
EP1065206B1 (fr) * 1999-07-02 2002-10-09 Pfizer Inc. Dérivés de tétrazolylalkyl-indole comme agents anti-inflammatoires et analgésiques
EA008242B1 (ru) 1999-12-08 2007-04-27 Фармация Корпорейшн Композиции на основе ингибитора циклооксигеназы-2 с быстро наступающим терапевтическим действием и способы лечения заболеваний
EP1572678A4 (fr) * 2002-12-19 2008-05-07 Elan Pharm Inc Antagonistes de la bradykinine a substitution n-phenylsulfonamide
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
KR100795462B1 (ko) * 2006-09-27 2008-01-16 한국생명공학연구원 인돌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 대사성 질환 예방 및 치료용 약학적 조성물
BRPI0718310A2 (pt) 2006-10-17 2013-11-19 Stiefel Laboratories Metabólitos de talarozol
US20120022121A1 (en) * 2007-11-29 2012-01-26 Dalton James T Indoles, derivatives and analogs thereof and uses therefor
EP2560956B1 (fr) * 2010-04-19 2016-10-26 Octeta Therapeutics, LLC Nouvelle synthèse de thiazolidinediones
JP5827328B2 (ja) 2010-07-07 2015-12-02 アーデリクス,インコーポレーテッド リン酸輸送を阻害する化合物及び方法
EP2590656B1 (fr) 2010-07-07 2017-11-15 Ardelyx, Inc. Composés et procédés permettant d'inhiber le transport du phosphate
JP5827326B2 (ja) 2010-07-07 2015-12-02 アーデリクス,インコーポレーテッド リン酸輸送を阻害する化合物及び方法
JP5827327B2 (ja) 2010-07-07 2015-12-02 アーデリクス,インコーポレーテッド リン酸輸送を阻害する化合物及び方法
PL2603507T3 (pl) 2010-08-10 2016-12-30 Synteza związków tiazolidynodionu
HUE031424T2 (en) 2010-08-10 2017-07-28 Octeta Therapeutics Llc New synthesis of thiazolidinedione compounds
US10266490B2 (en) * 2012-03-16 2019-04-23 Georgetown University Radioprotector compounds
US9808443B1 (en) 2016-11-28 2017-11-07 King Saud University Cyclooxygenase inhibitors
CN111004121A (zh) * 2019-12-09 2020-04-14 南京杰运医药科技有限公司 一种4-烷氧基乙酰乙酸酯类化合物的制备方法
CN112409281B (zh) * 2020-08-20 2022-11-18 上海大学 (e)-3-(3-氯-2-氟-6-(1h-四氮唑-1-基)苯基)丙烯酸的合成方法
CA3209491A1 (fr) 2021-03-15 2022-09-22 Saul Yedgar Dipalmitoyl-phosphatidyl-ethanol-amine conjuguee a l'acide hyaluronique en combinaison avec des medicaments anti-inflammatoires non steroidiens (ains) pour traiter ou soulager des maladies inflammatoire
EP4353262A4 (fr) * 2021-06-10 2025-05-21 UIF (University Industry Foundation), Yonsei University Nouveau composé présentant une activité inhibitrice contre la pendrine, et ses utilisations pharmaceutiques
CN116262721B (zh) * 2023-01-12 2026-03-13 浙江师范大学 一种二氢吲哚衍生物及吲哚衍生物的制备方法及产品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604253A (en) * 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
CO5190664A1 (es) * 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2

Also Published As

Publication number Publication date
IS5532A (is) 2000-06-13
ATE308519T1 (de) 2005-11-15
EA200000614A1 (ru) 2001-02-26
KR100404054B1 (ko) 2003-11-01
IL136885A0 (en) 2001-06-14
HN1997000098A (es) 1998-12-28
SK9912000A3 (en) 2001-11-06
UY25590A1 (es) 1999-09-27
HUP0102922A3 (en) 2003-06-30
AU748107B2 (en) 2002-05-30
OA11441A (en) 2004-04-27
BR9813124A (pt) 2000-10-10
HUP0102922A2 (hu) 2001-12-28
WO1999035130A1 (fr) 1999-07-15
JP3347136B2 (ja) 2002-11-20
PE20000055A1 (es) 2000-02-08
YU41600A (sh) 2003-08-29
TW436482B (en) 2001-05-28
NO20003451D0 (no) 2000-07-04
GT199800205A (es) 2000-06-21
EP1045833B1 (fr) 2005-11-02
AU1500599A (en) 1999-07-26
AP869A (en) 2000-09-04
DE69832200T2 (de) 2006-04-20
EP1045833A1 (fr) 2000-10-25
CN1284064A (zh) 2001-02-14
JP2002500217A (ja) 2002-01-08
NO20003451L (no) 2000-09-01
TR200001906T2 (tr) 2001-01-22
ES2255190T3 (es) 2006-06-16
AR016977A1 (es) 2001-08-01
CO4970807A1 (es) 2000-11-07
US6608070B1 (en) 2003-08-19
BG104643A (bg) 2001-02-28
AP9801423A0 (en) 1998-12-31
CA2316863A1 (fr) 1999-07-15
DE69832200D1 (de) 2005-12-08
PA8466201A1 (es) 2000-09-29
PL341696A1 (en) 2001-04-23
MA24736A1 (fr) 1999-10-01
UY25332A1 (es) 2001-01-31
HRP20000454A2 (en) 2001-04-30
KR20010033859A (ko) 2001-04-25
ID24876A (id) 2000-08-31
TNSN99001A1 (fr) 2005-11-10
ZA9911B (en) 2000-07-04
SA99191299A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
MA24736A1 (fr) Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques
MA26831A1 (fr) Derives de benzodiazepine."
DK1140935T3 (da) 1,2-anellerede quinolinderivater
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
MA25527A1 (fr) Composition d'encollage.
IT1291709B1 (it) Analoghi di buprenorfina aventi proprieta' analgesiche.
IT1304008B1 (it) Dispositivo per l'eliminazione di ratti e simili.
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
BR9708948A (pt) 1,3 - Benzodioxois substituídos
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
DK1175397T3 (da) 3,3-substituerede indolinderivater
ES1044994Y (es) Casita infantil perfeccionada.
ES1042703Y (es) "cuadro perfeccionado".
IT1304821B1 (it) Contenitore-programmatore per l'assunzione dei farmaci.
ES1034234Y (es) Babero perfeccionado.
ES1042694Y (es) "expositor perfeccionado".
ITCS990004V0 (it) "termocamin0 c.c.m."
ES1038556Y (es) "nuevo atril".
ES1037970Y (es) "pernito perfeccionado".
IT1283187B1 (it) "elettrovalvola."
UA2402S (uk) Пляшка "тутті-фрутті"